| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | Director | Common Stock | 10,666 | $810,616 | $76.00 | 05 Jan 2026 | Direct |
| PTC THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 0 | $238,040 | $27.05 | 05 Jan 2026 | Direct |
| Whitehawk Therapeutics, Inc. | Director | Stock Option (right to buy) | 40,006 | 12 Jun 2025 | Direct | ||
| Editas Medicine, Inc. | Director | Stock Option (right to buy) | 25,000 | 30 May 2024 | Direct | ||
| CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Stock Options (Right to buy) | 0 | 15 Jul 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | 02 Jan 2026 | 5 | -$21,624 | 4 | Director | 06 Jan 2026, 17:20 |
| PTCT | PTC THERAPEUTICS, INC. | 03 Dec 2025 | 3 | -$23,515 | 4 | Director | 05 Dec 2025, 17:20 |
| PTCT | PTC THERAPEUTICS, INC. | 21 Nov 2025 | 3 | -$283,400 | 4 | Director | 25 Nov 2025, 17:20 |
| PTCT | PTC THERAPEUTICS, INC. | 12 Nov 2025 | 3 | -$205,031 | 4 | Director | 14 Nov 2025, 17:20 |
| PTCT | PTC THERAPEUTICS, INC. | 30 Oct 2025 | 4 | -$631,587 | 4 | Director | 31 Oct 2025, 17:20 |
| PTCT | PTC THERAPEUTICS, INC. | 03 Oct 2025 | 15 | -$772,690 | 4 | Director | 07 Oct 2025, 17:20 |
| PTCT | PTC THERAPEUTICS, INC. | 11 Sep 2025 | 8 | -$649,399 | 4 | Director | 16 Sep 2025, 17:00 |
| WHWK | Whitehawk Therapeutics, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 16:54 |
| PTCT | PTC THERAPEUTICS, INC. | 03 Jan 2025 | 2 | $0 | 4 | Director | 07 Jan 2025, 17:20 |
| WHWK | Aadi Bioscience, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:09 |
| EDIT | Editas Medicine, Inc. | 30 May 2024 | 1 | $0 | 4 | Director | 03 Jun 2024, 16:30 |
| PTCT | PTC THERAPEUTICS, INC. | 15 Feb 2024 | 2 | $0 | 4 | Director | 16 Feb 2024, 16:10 |
| WHWK | Aadi Bioscience, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 20:19 |
| EDIT | Editas Medicine, Inc. | 01 Jun 2023 | 1 | $0 | 4 | Director | 05 Jun 2023, 16:30 |
| PTCT | PTC THERAPEUTICS, INC. | 22 May 2023 | 18 | -$581,515 | 4 | Director | 24 May 2023, 16:12 |
| PTCT | PTC THERAPEUTICS, INC. | 21 Apr 2023 | 2 | -$238,258 | 4 | Director | 25 Apr 2023, 16:08 |
| PTCT | PTC THERAPEUTICS, INC. | 05 Jan 2023 | 2 | $0 | 4 | Director | 09 Jan 2023, 15:13 |
| WHWK | Aadi Bioscience, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:28 |
| EDIT | Editas Medicine, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:30 |
| PTCT | PTC THERAPEUTICS, INC. | 07 Jan 2022 | 2 | $0 | 4 | Director | 11 Jan 2022, 15:12 |
| WHWK | Aadi Bioscience, Inc. | 08 Sep 2021 | 1 | $0 | 4 | Director | 10 Sep 2021, 16:47 |
| WHWK | Aadi Bioscience, Inc. | 08 Sep 2021 | 0 | $0 | 3 | Director | 10 Sep 2021, 16:40 |
| EDIT | Editas Medicine, Inc. | 03 Sep 2021 | 1 | $0 | 4 | Director | 08 Sep 2021, 16:33 |
| EDIT | Editas Medicine, Inc. | 03 Sep 2021 | 0 | $0 | 3 | Director | 08 Sep 2021, 16:28 |
| /report/000156218021004984-reeve-emma-2021-07-15 | CONSTELLATION PHARMACEUTICALS INC | 15 Jul 2021 | 7 | $0 | 4 | Chief Financial Officer | 19 Jul 2021, 17:38 |